The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and investor relations are paramount, writes Jeff Walsh, CEO of nChroma Bio.
Patient advocacy groups, when engaged through networked approaches, can strengthen clinical trial recruitment by uniting patient trust, sponsor efficiency, and a streamlined, patient-centric experience.
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026. Understand what is taxed and how to minimize tax exposure.
Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.
Implement data-driven strategies to accelerate enrollment and stop timeline delays. Focus on optimizing site performance and embracing patient-centric recruitment models to reach diverse populations effectively.
Discover how intensification strategies reduce costs and waste while boosting throughput, sustainability, and operational value, which offers a smarter, more scalable approach to manufacturing.
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
When it comes to furthering AAV's potential in the wider biopharmaceutical pipeline, partnering with a CDMO that can foment an optimal analytical and manufacturing strategy is crucial.
